Using Systematic Reviews and Registers of Ongoing Trials for Scientific and Ethical Trial Design, Monitoring, and Reporting
Published 1 January 2001
Iain Chalmers
Citations35
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
This chapter contains section titled: Summary Points Questionable use of Limited Resources Ethical Concerns Distorted Research Agendas Registration of Planned and Ongoing Trials to Inform Decisions on New Trials Registration of Trials to Reduce Reporting Biases Ethical and Scientific Monitoring of Ongoing Trials Interpreting the Results from new Trials Acknowledgements
Keywords
Decision SciencesMedicineHealth Professions
Progress in Cardiovascular DiseasesBeta blockade during and after myocardial infarction: An overview of the randomized trials
3,239 Citations1985Salim Yusuf, Richard Peto +3 more
The aim has been not only to review the 65-odd randomized beta blocker trials but also to demonstrate that when many randomized trials have all applied one general approach to treatment, it is often not appropriate to base inference on individual trial results.
JAMAImproving the Quality of Reporting of Randomized Controlled Trials
3,138 Citations1996Colin B. Begg
Systematic Reviews in Health Care : Meta-Analysis in Context
2,321 Citations2000Matthias Egger, George Davey Smith +1 more
The second edition of this best-selling book has been thoroughly revised and expanded to reflect the significant changes and advances made in systematic reviewing.
BMJ<i>meta-analysis</i> bias in location and selection of studies
1,383 Citations1998Matthias Egger, George Davey Smith
The LancetEfficacy of adjuvant fluorouracil and folinic acid in colon cancer
1,060 Citations1995
It is concluded that fluorouracil plus high-dose folinic acid is a well-tolerated and effective 6-month adjuvant regimen for colon cancer.
BMJThe scandal of poor medical research
872 Citations1994D G Altman
The authors need less research, better research, and research done for the right reasons, and researchers who use the wrong techniques, use the right techniques wrongly, misinterpret their results, report their results selectively, cite the literature selectively, and draw unjustified conclusions.
Journal of Clinical OncologyPublication bias: the case for an international registry of clinical trials.
758 Citations1986R. J. Simes
A model is proposed for reviewing clinical trial results which is free from publication bias based on the selection of trials registered in advance in a registry, and the value and importance of an international registry of all clinical trials are illustrated.
JAMAEffects of Prophylactic Antiarrhythmic Drug Therapy in Acute Myocardial Infarction
571 Citations1993Koon Teo
The routine use of class I antiarrhythmic agents after myocardial infarction is associated with increased mortality and the limited data on amiodarone appear promising.
JAMAUnderreporting Research Is Scientific Misconduct
556 Citations1990lain Chalmers
An extended use of prospective registration of trials at inception, as well as benefiting clinical research in other ways, could help people to play their respective roles in reducing underreporting of clinical trials.
BMJContent and quality of 2000 controlled trials in schizophrenia over 50 years
364 Citations1998B. Thornley, Clive E Adams
The drug regulatory authorities should stipulate that the results of both explanatory and pragmatic trials are necessary before a compound is given a licence for everyday use, and much scope for well planned, conducted, and reported trials is left.
Journal of Clinical EpidemiologyCumulative meta-analysis of clinical trials builds evidence for exemplary medical care
356 Citations1995Joseph Lau, Christopher H. Schmid +1 more
Application of the technique to the randomized control trials of streptokinase treatment of acute myocardial infarction, reduction of peri-operative mortality by antibiotic prophylaxis, and prevention of death from bleeding peptic ulcers has revealed efficacy years before it was suspected by any other means.
JAMAEffects of Prophylactic Lidocaine in Suspected Acute Myocardial Infarction
320 Citations1988Stephen MacMahon
An overview of all the trial results does not provide good evidence as to whether prophylactic lidocaine is likely to be helpful or harmful; to answer this question reliably, future trials will need to involve large numbers of patients and prolonged follow-up.
Archives of Internal MedicineMeta-analytic Evidence Against Prophylactic Use of Lidocaine in Acute Myocardial Infarction
243 Citations1989Louis K. Hine
Lidocaine administered to monitored patients during the prehospital phase of AMI will not reduce mortality by a clinically important amount and lidocaineadministered in the hospital phase of monitored, uncomplicated AMI may increase mortality among recipients with proved AMI.
New England Journal of MedicineEffect of Bright Light in the Hospital Nursery on the Incidence of Retinopathy of Prematurity
230 Citations1985Penny Glass, Gordon B. Avery +4 more
It is concluded that the high level of ambient illumination commonly found in the hospital nursery may be one factor contributing to retinopathy of prematurity and that safety standards with regard to current lighting practices should be reassessed.
New England Journal of MedicineLack of Efficacy of Light Reduction in Preventing Retinopathy of Prematurity
224 Citations1998James D. Reynolds, Robert J. Hardy +4 more
BMJWhat do I want from health research and researchers when I am a patient?
210 Citations1995Iain Chalmers
The impression is left that health researchers could serve the interests of the public more effectively in a variety of ways, and that they would be helped to do so by greater lay involvement in planning and promoting health research.
The American Journal of CardiologyEffect of antiarrhythmic drugs on mortality after myocardial infarction
199 Citations1983Curt D. Furberg
Increased attention to methodologic issues, such as selection of appropriate study populations, intervention strategies and larger sample sizes, is required to resolve the uncertainty in the treatment of coronary patients with ventricular arrhythmias.
BMJAre research ethics committees behaving unethically? Some suggestions for improving performance and accountability: Fig 1
186 Citations1996Julian Savulescu, Iain Chalmers +1 more
The performance and accountability of research ethics committees would be improved if they required those proposing research to present systematic reviews of relevant previous research in support of their applications.
Journal of Medical EthicsMRC Guidelines for Good Clinical Practice in Clinical Trials
160 Citations1999Duncan Vere
Steven Edwards's collection provides a welcome addition to the underexplored area of philosophical issues in nursing as a well-founded introduction to this novel area for undergraduate and postgraduate students in nursing and other interested parties.
JAMADiscussion Sections in Reports of Controlled Trials Published in General Medical Journals
159 Citations1998Mike Clarke, Iain Chalmers
There is little evidence that journals have adequately implemented the CONSORT recommendation that results of an RCT be discussed in light of the totality of the available evidence.
PEDIATRICSRetrospective and Prospective Identification of Unpublished Controlled Trials: Lessons From a Survey of Obstetricians and Pediatricians
129 Citations1989Jini Hetherington, Kay Dickersin +2 more
It was concluded that publication bias will not be addressed successfully by attempts to obtain information about unpublished trials retrospectively, but prospective registration of trials at inception appears to be a feasible approach to reducing publication bias and its adverse consequences.
The LancetThe agonising negative trend in monitoring of clinical trials
125 Citations1999David L. DeMets, Stuart Pocock +1 more
All trials and their DSMBs should consider ahead of time the possibility of unexpectedly harmful results, and should document appropriately the statistical guidelines and the decision-making process required to cope with such undesirable events.
The LancetHow can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing
113 Citations1999Iain Chalmers, Douglas G. Altman
JAMAThe Role of Meta-analysis in the Regulatory Process for Foods, Drugs, and Devices
101 Citations1999Jesse A. Berlin
Overall, meta-analysis adds evidence through the synthesis study findings and permits examination of how treatment effects vary across of subgroups, such as age and sex, and across study settings.
BMJTime to register randomised trials
90 Citations1999R. Horton, Richard Smith
A systematic review of trials using ondansetron to treat postoperative nausea and vomiting and those conducting systematic reviews need to be able to identify all trials begun on a subject to avoid the problem of publication bias.
BMJRegistering clinical trials
75 Citations1999Alison Tonks
Clinical trials should be registered so that essential details are made public from a trial's inception, rather than from publication many years later.
International Journal of CardiologyThe effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias
75 Citations1993Alison Cowley, A. M. Skene +2 more
There were nine deaths among the 49 patients treated with lorcainide compared with only one in the patients given placebo, consistent with the results of the First and Second Cardiac Arrhythmia Suppression trials (CAST and CAST-II).
Controlled Clinical TrialsReport from the panel on the case for registers of clinical trials at the eighth annual meeting of the society for clinical trials
59 Citations1988Kay Dickersin
The experience gleaned by those involved with two existing trial registers, the International Committee on Thrombosis and Haemostasis Registry and the Oxford Database of Perinatal Trials, can be used to provide insight into the issues generic to trial registration.
BMJBeing a modern pharmaceutical company
55 Citations1998Robert Sykes
The pharmaceutical industry has several important roles today that would not have been apparent as recently as 10-15 years ago, but one substantial outcome is a better understanding of the need for openness and transparency in clinical trials.
StrokeConsiderations in the Design of Clinical Trials of Neuroprotective Therapy in Acute Stroke
52 Citations1996Paul Dorman, Peter Sandercock
If tens of thousands of patients are to be recruited into trials of neuroprotective therapy, it is essential that the trials have simple practicable designs that allow participation not only by interested university hospitals but also busy general hospitals with few research resources.
BMJDenmark takes a lead on research ethics
13 Citations1998S. Goldbeck-Wood
Danish medical researchers will soon have to observe tough new regulations to gain ethics committee approval for their research, according to a decision taken by the Danish national research ethics committee.
Cardiovascular Drugs and TherapyAlternatives to mega-trials in cardiovascular disease
7 Citations1997J R Hampton
The dominant role of trials involving thousands of patients-the mega-trials—in cardiovascular disease is considered, and properly organized trials designed to establish whether or not two treatments have an equivalent effect seem to offer the best alternative to mega-Trials.
The LancetResearch funding
4 Citations1999Charles Warlow, Peter Sandercock +2 more
The Patient-Centered Outcomes Research Institute (PCORI) is a nonprofit organization authorized by Congress to fund comparative clinical effectiveness research, or CER, designed to produce reliable, useful information that will help patients, family caregivers, clinicians, employers, insurers, policy makers and others make betterinformed health and healthcare decisions.
